secwatch / observer
HHS HARTE HANKS INC
CIK 0000045919 50 ready 8-Ks latest August 19, 2026, 4:17 PM ET RSS · JSON
Activity: NORMAL 1 filings / 30d vs 0 baseline
Ready 8-Ks 50
Latest filing August 19, 2026, 4:17 PM ET
Top materiality 0.90
Event mix earnings ×19 · other_material ×11 · leadership ×9
Sentiment 16 pos · 10 neg · 24 neu
Latest earnings reported 2025-Q3
Executive change recent →

Recent 8-K filings for HHS

Executive changes

Departed

Kirk Davis

Chief Executive Officer
HHS · HARTE HANKS INC
Effective
2025-02-14
Filed
January 28, 2025, 6:59 PM ET
Kirk Davis departing the Company effective as of February 14, 2025
Appointed (interim)

David Fisher

Interim Chief Operating Officer
HHS · HARTE HANKS INC
Effective
2025-01-27
Filed
January 28, 2025, 6:59 PM ET
appointing David Fisher to serve as the Interim Chief Operating Officer, effective as of this date
Appointed

David Garrison

Chief Financial Officer
HHS · HARTE HANKS INC
Effective
2024-01-29
Filed
February 5, 2024, 6:59 PM ET
Harte Hanks, Inc. (the “Company”) announced today that David Garrison who has been serving as Interim Chief Financial Officer was appointed to role of permanent Chief Financial Officer ("CFO") of the Company, effective as of January 29, 2024.
Appointed

Elizabeth Ross

member of the Board
HHS · HARTE HANKS INC
Effective
2024-01-02
Filed
January 5, 2024, 6:59 PM ET
On December 29, 2023, the Board of Directors (the “Board”) of Harte Hanks appointed Elizabeth Ross as a member of the Board, effective as of January 2, 2024.
Departed (interim)

Lauri Kearnes

Chief Financial Officer
HHS · HARTE HANKS INC
Effective
2023-10-13
Successor
David Garrison
Filed
October 17, 2023, 7:59 PM ET
Lauri Kearnes departing the Company as of October 13, 2023
Appointed (interim)

David Garrison

Interim Chief Financial Officer
HHS · HARTE HANKS INC
Effective
2023-10-23
Filed
October 17, 2023, 7:59 PM ET
appointing David Garrison as the Interim CFO, effective as of October 23, 2023
Departed

Brian Linscott

Chief Executive Officer
HHS · HARTE HANKS INC
Effective
2023-06-16
Successor
Kirk Davis
Filed
June 20, 2023, 7:59 PM ET
Brian Linscott departing the Company as of June 16, 2023
Appointed

Kirk Davis

Chief Executive Officer
HHS · HARTE HANKS INC
Effective
2023-06-19
Filed
June 20, 2023, 7:59 PM ET
appointing Kirk Davis as Chief Executive Officer and nominating Mr. Davis to the Board, effective as of June 19, 2023
Departed

Albert V. Tobia Jr.

Director
HHS · HARTE HANKS INC
Effective
2021-09-24
Filed
September 24, 2021, 7:59 PM ET
On September 24, 2021, Harte Hanks, Inc. (the “Company”) announced that Albert V. Tobia Jr. will resign as a director on the Board of Directors (the “Board”) of the Company.

Earnings & guidance

2025-Q3 EPS reported -$0.41 filing →

Materiality & sentiment trend

Max materiality 0.90 · Median 0.65 · Most common event earnings

16 positive 10 negative 24 neutral

source · HHS on sec.gov